Gut microbiota dysbiosis and diarrhea in kidney transplant recipients/Experiment 5

From BugSigDB


Reviewed Marked as Reviewed by Atrayees on 2023-6-7

Curated date: 2023/04/19

Curator: Ufuoma Ejite

Revision editor(s): Ufuoma Ejite, Victoria

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Diarrhea Diarrhea,Diarrhoea,Watery stool,diarrhea
Group 0 name Corresponds to the control (unexposed) group for case-control studies
2000 mg/day MMF Dosage No Diarrhea Group
Group 1 name Corresponds to the case (exposed) group for case-control studies
2000 mg/day MMF Dosage Diarrhea Group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
2000 mg/day MMF Dosage administered to the Diarrhea Group
Group 0 sample size Number of subjects in the control (unexposed) group
25
Group 1 sample size Number of subjects in the case (exposed) group
13

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4-V5
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.15
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Matched on Factors on which subjects have been matched on in a case-control study
intake of diabetes medication


Signature 1

Reviewed Marked as Reviewed by Atrayees on 2023-6-7

Curated date: 2023/04/19

Curator: Ufuoma Ejite

Revision editor(s): Ufuoma Ejite, Atrayees

Source: Table S6

Description: Differential microbial abundance between 2000 mg/day MMF Dosage No Diarrhea Group and 2000 mg/day MMF Dosage Diarrhea Group

Abundance in Group 1: decreased abundance in 2000 mg/day MMF Dosage Diarrhea Group

NCBI Quality ControlLinks
Eubacterium
Coprococcus
Anaerostipes
Ruminococcus
Faecalibacterium
Romboutsia
Ruminiclostridium
Dorea
Oscillibacter
Bifidobacterium
Fusicatenibacter
Blautia
Bacteroides
Gemmiger
Coprobacillus
Thomasclavelia

Revision editor(s): Ufuoma Ejite, Atrayees

Signature 2

Reviewed Marked as Reviewed by Atrayees on 2023-6-7

Curated date: 2023/04/19

Curator: Ufuoma Ejite

Revision editor(s): Ufuoma Ejite, Atrayees

Source: Table S6

Description: Differential microbial abundance between 2000 mg/day MMF Dosage No Diarrhea Group and 2000 mg/day MMF Dosage Diarrhea Group

Abundance in Group 1: increased abundance in 2000 mg/day MMF Dosage Diarrhea Group

NCBI Quality ControlLinks
Enterococcus
Lachnoclostridium
Streptococcus
Intestinibacter

Revision editor(s): Ufuoma Ejite, Atrayees